首页> 外文期刊>中国神经再生研究(英文版) >Inhibition of neurite outgrowth using commercial myelin associated glycoprotein-Fc in neuro-2a cells
【24h】

Inhibition of neurite outgrowth using commercial myelin associated glycoprotein-Fc in neuro-2a cells

机译:使用商业髓磷脂相关糖蛋白-Fc在神经2a细胞中抑制神经突生长

获取原文
获取原文并翻译 | 示例
       

摘要

Myelin-associated glycoprotein (MAG) inhibits the growth of neurites from nerve cells. Extraction and purification of MAG require com-plex operations; therefore, we attempted to determine whether commercially available MAG-Fc can replace endogenous MAG for research purposes. Immunofluorescence using specific antibodies against MAG, Nogo receptor (NgR) and paired immunoglobulin-like receptor B (PirB) was used to determine whether MAG-Fc can be endocytosed by neuro-2a cells. In addition, neurite outgrowth of neuro-2a cells treated with different doses of MAG-Fc was evaluated. Enzyme linked immunosorbent assays were used to measure RhoA activity. West-ern blot assays were conducted to assess Rho-associated protein kinase (ROCK) phosphorylation. Neuro-2a cells expressed NgR and PirB, and MAG-Fc could be endocytosed by binding to NgR and PirB. This activated intracellular signaling pathways to increase RhoA activity and ROCK phosphorylation, ultimately inhibiting neurite outgrowth. These findings not only verify that MAG-Fc can inhibit the growth of neural neurites by activating RhoA signaling pathways, similarly to endogenous MAG, but also clearly demonstrate that commercial MAG-Fc is suitable for experimental studies of neurite outgrowth.
机译:髓磷脂相关糖蛋白(MAG)抑制神经细胞神经突的生长。 MAG的提取和纯化需要复杂的操作;因此,我们尝试确定市售的MAG-Fc是否可以代替内源性MAG用于研究目的。使用针对MAG,Nogo受体(NgR)和成对的免疫球蛋白样受体B(PirB)的特异性抗体的免疫荧光法确定MAG-Fc是否可以被神经2a细胞内吞。另外,评估了用不同剂量的MAG-Fc处理的神经2a细胞的神经突生长。酶联免疫吸附测定法用于测量RhoA活性。进行蛋白质印迹分析以评估Rho相关蛋白激酶(ROCK)的磷酸化。 Neuro-2a细胞表达NgR和PirB,而MAG-Fc可通过与NgR和PirB结合而被内吞。这种激活的细胞内信号传导途径可以增加RhoA活性和ROCK磷酸化,最终抑制神经突的生长。这些发现不仅证实了MAG-Fc与内源性MAG相似,还可以通过激活RhoA信号通路抑制神经突的生长,而且清楚地证明了商用MAG-Fc适用于神经突生长的实验研究。

著录项

  • 来源
    《中国神经再生研究(英文版)》 |2018年第11期|1893-1899|共7页
  • 作者单位

    Department of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China;

    Department of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China;

    Department of Vascular Surgery, People's Hospital of Gansu Province, Lanzhou, Gansu Province, China;

    Department of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China;

    Department of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China;

    Department of Pathophysiology, Shanxi Medical University, Taiyuan, Shanxi Province, China;

  • 收录信息 中国科学引文数据库(CSCD);中国科技论文与引文数据库(CSTPCD);
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类
  • 关键词

  • 入库时间 2022-08-19 03:44:23
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号